PLSG :: Pittsburgh Life Sciences Greenhouse ::

Cernostics

Company Name
Cernostics

Description of Company Mission

Cernostics, Inc. is developing technologies that will redefine the way cancer is diagnosed. Through a complex integration of quantitative pathology and advanced informatics supported by a robust electronic medical record management system, Cernostics is discovering new ways to find, see, and treat cancer.

Cernostics has a personalized healthcare approach to cancer diagnosis and treatment utilizing technology and intellectual property based on a systems approach to evaluating patient tissue samples including multiplexed florescence microscopy and imaging technology that holds great potential to produce better, safer and more cost-effective results.

Industry
HIT/Diagnostics

Stage of Commercialization
Early Stage

Market Size
$2B

PLSG Funding to Date
$150,000

CEO Name
Michael Hoerres

PLSG Executive in Residence
D. Taylor

Number of Employees
2

Location
Pittsburgh, PA

< Prev		Next >